Literature DB >> 15774507

Tissue preconditioning may explain concentric lesions in Baló's type of multiple sclerosis.

Christine Stadelmann1, Sam Ludwin, Takeshi Tabira, Andras Guseo, Claudia F Lucchinetti, Lorant Leel-Ossy, Artemio T Ordinario, Wolfgang Brück, Hans Lassmann.   

Abstract

Lesions of Baló's concentric sclerosis are characterized by alternating layers of myelinated and demyelinated tissue. The reason for concentric demyelination in this variant of multiple sclerosis is unclear. In the present study we investigated the immunopathology in autopsy tissue of 14 patients with acute multiple sclerosis or fulminant exacerbations of chronic multiple sclerosis with Baló-type lesions in the CNS, focusing on the patterns of tissue injury in actively demyelinating lesions. We found that all active concentric lesions followed a pattern of demyelination that bears resemblances to hypoxia-like tissue injury. This was associated with high expression of inducible nitric oxide synthase in macrophages and microglia. At the edge of active lesions and, less consistently, in the outermost layer of preserved myelin, proteins involved in tissue preconditioning, such as hypoxia-inducible factor 1alpha and heat-shock protein 70, were expressed mainly in oligodendrocytes and to a lesser degree also in astrocytes and macrophages. Due to their neuroprotective effects, the rim of periplaque tissue, where these proteins are expressed, may be resistant to further damage in an expanding lesion and may therefore remain as a layer of preserved myelinated tissue.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15774507     DOI: 10.1093/brain/awh457

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  52 in total

1.  CADASIL mutation and Balo concentric sclerosis: a link between demyelination and ischemia?

Authors:  Tanuja Chitnis; Travis J Hollmann
Journal:  Neurology       Date:  2012-01-04       Impact factor: 9.910

Review 2.  Heat shock protein 70: roles in multiple sclerosis.

Authors:  María José Mansilla; Xavier Montalban; Carmen Espejo
Journal:  Mol Med       Date:  2012-09-07       Impact factor: 6.354

Review 3.  Role of mitochondria in multiple sclerosis.

Authors:  Bernadette Kalman
Journal:  Curr Neurol Neurosci Rep       Date:  2006-05       Impact factor: 5.081

4.  Lesion genesis in a subset of patients with multiple sclerosis: a role for innate immunity?

Authors:  Christina Marik; Paul A Felts; Jan Bauer; Hans Lassmann; Kenneth J Smith
Journal:  Brain       Date:  2007-11       Impact factor: 13.501

5.  Baló's concentric sclerosislike lesion in the brainstem of a multiple sclerosis patient.

Authors:  Richiro Kishimoto; Ichiro Yabe; Masaaki Niino; Kazunori Sato; Sachiko Tsuji; Seiji Kikuchi; Hidenao Sasaki
Journal:  J Neurol       Date:  2008-02-25       Impact factor: 4.849

Review 6.  MRI characteristics of atypical idiopathic inflammatory demyelinating lesions of the brain : A review of reported findings.

Authors:  A Seewann; C Enzinger; M Filippi; F Barkhof; A Rovira; A Gass; D Miller; X Montalban; A Thompson; T Yousry; M Tintore; N de Stefano; J Palace; M Rovaris; C Polman; F Fazekas
Journal:  J Neurol       Date:  2007-11-15       Impact factor: 4.849

7.  Apoptosis of oligodendrocytes in the central nervous system results in rapid focal demyelination.

Authors:  Andrew V Caprariello; Saisho Mangla; Robert H Miller; Stephen M Selkirk
Journal:  Ann Neurol       Date:  2012-09       Impact factor: 10.422

Review 8.  Review: Mitochondria and disease progression in multiple sclerosis.

Authors:  D Mahad; H Lassmann; D Turnbull
Journal:  Neuropathol Appl Neurobiol       Date:  2008-12       Impact factor: 8.090

Review 9.  Demyelinating diseases.

Authors:  S Love
Journal:  J Clin Pathol       Date:  2006-11       Impact factor: 3.411

Review 10.  The pathological spectrum of CNS inflammatory demyelinating diseases.

Authors:  Wei Hu; Claudia F Lucchinetti
Journal:  Semin Immunopathol       Date:  2009-09-25       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.